PubMed

Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong KK.

Br J Ophthalmol. 2004 Oct;88(10):1315-9.PMID: 15377558 [PubMed - indexed for MEDLINE]Related articlesFree article

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA.

Ophthalmology. 2003 Apr;110(4):667-73.PMID: 12689884 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Verteporfin in Photodynamic Therapy Study Group.

Ophthalmology. 2001 May;108(5):841-52.PMID: 11320011 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls.

Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hara W, Yoshida T, Tokoro T, Mochizuki M.

Am J Ophthalmol. 2008 Mar;145(3):518-526. Epub 2008 Jan 22.PMID: 18207125 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.

Lam DS, Liu DT, Fan DS, Lai WW, So SF, Chan WM.

Eye (Lond). 2005 Aug;19(8):834-40.PMID: 15375364 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

[No authors listed]

Arch Ophthalmol. 1999 Oct;117(10):1329-45. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10532441 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.

Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM; United Kingdom PDT Users Group.

Ophthalmology. 2005 Jul;112(7):1227-31.PMID: 15921757 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.

Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS, Li KK.

Ophthalmology. 2003 Dec;110(12):2395-402.PMID: 14644724 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.

Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M.

Am J Ophthalmol. 2004 Oct;138(4):602-7.PMID: 15488787 [PubMed - indexed for MEDLINE]Related articles

[Treatment of subfoveal choroidal neovascularization in pathologic myopia with photodynamic therapy: outcomes at 1 and 2 years of follow-up]

El Matri L, Bouraoui R, Merdassi A, Baccouri R, Mghaieth F, Ben Rejeb S, Meddeb S.

J Fr Ophtalmol. 2006 Sep;29(7):765-70. French. PMID: 16988626 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.

Pece A, Isola V, Vadalà M, Matranga D.

Retina. 2006 Sep;26(7):746-51.PMID: 16963846 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.

Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ.

Am J Ophthalmol. 2003 Nov;136(5):836-45.PMID: 14597034 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.

Pece A, Vadalà M, Isola V, Matranga D.

Am J Ophthalmol. 2007 Mar;143(3):449-54. Epub 2006 Dec 22.PMID: 17317390 [PubMed - indexed for MEDLINE]Related articles

Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.

Hussain N, Khanna R, Das T, Narayanan R, Sunday OT, Bansal AG, Reddy R.

Indian J Ophthalmol. 2008 Nov-Dec;56(6):465-8.PMID: 18974516 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.

Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH.

Clin Experiment Ophthalmol. 2003 Dec;31(6):476-81.PMID: 14641153 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2001 Feb;119(2):198-207.PMID: 11176980 [PubMed - indexed for MEDLINE]Related articles

Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.

Maár N, Ergun E, Luksch A, Stur M.

Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1262-6. Epub 2006 Mar 15.PMID: 16538450 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.

Costagliola C, Campa C, Incorvaia C, Parmeggiani F, Menzione M, Della Corte M, Rinaldi M, Romano M, Semeraro F.

Eur J Ophthalmol. 2008 Nov-Dec;18(6):955-9. Erratum in: Eur J Ophthalmol. 2009 Mar-Apr;19(2):329. PMID: 18988168 [PubMed - indexed for MEDLINE]Related articles

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.

Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.

Br J Ophthalmol. 2006 Mar;90(3):337-41.PMID: 16488958 [PubMed - indexed for MEDLINE]Related articlesFree article